Intellego Stock Plunges After CEO Faces Scrutiny on Financial Health

Intellego, a UV technology company, experienced a turbulent trading day characterized by a sharp stock reversal following the release of preliminary quarterly figures and a company presentation hosted by DNB Carnegie. During the presentation, CEO Claes Lindahl addressed pointed questions from analysts regarding the company's financial health. According to Dagens industri, inquiries focused on Intellego's cash reserves, accounts receivable management, customer acquisition, and competitive positioning within the market. Subsequent to the presentation and Q&A session, Intellego's stock price declined, negating earlier gains. In response to market concerns and issues raised during the DNB Carnegie event, Intellego issued a clarifying press release in the afternoon, providing additional context and information intended to address investor anxieties.